Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”

By Alama Angela   Coco Simona   Vanni Irene   Grossi Francesco  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1309-1309

MDPI

Access to resources Recommend Favorite

Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”

By Nicolazzo Chiara   Raimondi Cristina   Loreni Flavia   Gazzaniga Paola   Gradilone Angela  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1308-1308

MDPI

Access to resources Recommend Favorite

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

By Coco Simona   Alama Angela   Vanni Irene   Fontana Vincenzo   Genova Carlo   Dal Bello Maria Giovanna   Truini Anna   Rijavec Erika   Biello Federica   Sini Claudio   Burrafato Giovanni   Maggioni Claudia   Barletta Giulia   Grossi Francesco  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 1035-1035

MDPI

Access to resources Recommend Favorite

An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC)

By Quinton Cindy   Ellis Peter M.  

Cancers, Vol. 3, Iss. 3, 2011-09 ,pp. : 3506-3524

MDPI

Access to resources Recommend Favorite

Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells

By Klimaszewska-Wiśniewska Anna   Hałas-Wiśniewska Marta   Grzanka Alina   Grzanka Dariusz  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-02 ,pp. : 661-661

MDPI

Access to resources Recommend Favorite